Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients
Observational Study
[키워드] abnormality
acute respiratory syndrome
adjusted
Admission
alanine aminotransferase
albumin level
alkaline phosphatase
ALP
ALT
Asian
Aspartate aminotransferase
association
AST
Baltimore
Bilirubin
bilirubin.
can be used
Clinical characteristics
Clinical outcome
collected
coronavirus
COVID-19
COVID-19 patient
COVID-19 severity
Cox regression
Cox regression analysis
demographic
disease severity
drugs
elevated
Factor
highest
Hospital admission
Hospitalization
Hospitalized
hospitalized patient
in-hospital mortality
Johns Hopkin
Laboratory
liver
Liver injury
Liver tests
Measures
mechanical ventilation
mortality risk
obesity
Older age
Other
outcome
Patient
patients
patients with COVID-19
predict
Prevalence
prevalent
Prognosis
retrospective
risk
serum
severe acute respiratory syndrome coronavirus 2
severity
severity and prognosis
severity of COVID-19
System
the patient
therapy
total bilirubin
Treatment
United States
variable
was used
with COVID-19
[DOI] 10.3748/wjg.v28.i5.570 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.3748/wjg.v28.i5.570 PMC 바로가기 [Article Type] Observational Study